Skip to main content
Figure 4 | Molecular Pain

Figure 4

From: NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors

Figure 4

Effect of intraperitoneal (A, C) or intragastric (B, D) treatment with NMP-7 on tissue myeloperoxidase (MPO) activity (Panel A and B) and paw volume (Panel C and D). Bars represent mean ± SEM MPO units per mg of tissue (Panel A, B) and mean ± SEM of paw volumes (Panel C, D) of 7–10 mice when NMP-7 was delivered i.p. and 4–5 mice when delivered i.g. ### p < 0.001 when compared to the non-inflamed group (20 μl of PBS injected intraplantarily), ns = non significant relative to the inflamed vehicle-treated controls (PBS +5% DMSO).

Back to article page

Molecular Pain

ISSN: 1744-8069

Contact us